【レポートの概要(一部)】
1. Executive Summary
1.1 Sector Highlights
1.2 Aim, Scope and Format of This Report
1.3 Chapter Outline
1.4 Research and Analysis Methods
1.5 Glossary of Terms Relating to the Report
2. Introduction to Needle-Free Delivery of Drugs/Vaccines
2.1 What is Needle-Free Technology?
2.1.1 History of Needle-Free Injections (NFI)
2.2 Why the Need For Needle-Free Delivery Technology?
2.2.1 Needle Stick Injury
2.2.1.1 Blood-Borne Pathogens and Needle Stick Injury
2.2.1.2 Accidental Needle Stick Injury: A Serious Healthcare Problem
2.3 Clinical Settings Where Needle-Free Delivery Technology Will Be Beneficial
2.3.1 Pain Management
2.3.1.1 Pain Management: Using NFI Devices to Administer Lidocaine
2.3.2 Vaccine Delivery: Improving Immune Response
2.3.2.1 The Global Vaccine Market, 2014-2024
2.3.2.2 Needle-Free Vaccine Delivery
2.3.2.3 Mass Immunisation
2.3.3 Insulin Delivery For Diabetics
2.3.4 Paediatric Injections
2.3.5 Other Uses For Needle-Free Injection Technology
2.4 Advantages and Disadvantages of Needle-Free Injections
2.5 The Needle-Free Delivery Market
2.5.1 Jet Injectors
2.5.1.1 Concerns About Multi-use Nozzle Jet injectors (MUNJIs)
2.5.1.2 Strengths and Weaknesses of Jet Injectors
2.5.2 Competing Needle-Free Technologies
2.5.2.1 Novel Needle Technology
2.5.2.1.1 Pen Needles
2.5.2.1.2 Microneedles
2.5.2.1.3 Hollow Microneedles
2.5.2.1.4 Solid Coated Microneedles
2.5.2.1.5 Solid Biodegradable Microneedles
2.5.2.1.6 Solid Uncoated Microneedles
2.5.2.1.7 Selection of Microneedles
2.5.2.2 Inhaler Technology
2.5.2.3 Transdermal Patch Technology
2.6 Regulation of the Needle-Free Delivery Market
2.6.1 The US Regulation System
2.6.1.1 Combination Products
2.6.1.2 FDA Statement Clamps Down On Delivery of Medications in Non-approved Needle-Free Devices
2.6.2 The European Regulation System
2.6.2.1 Post Marketing Surveillance in the EU
3. The Global Needle-Free Injection Device Market, 2014-2024
3.1 The Needle-Free Delivery Technology Market: Overview
3.2 The Needle-Free Delivery Technology Market by Segments, 2012-2013
3.3 The Needle-Free Delivery Market Forecast, 2014-2024
3.4 Needle-Free Delivery Technology: Market Trends, 2014-2024
4. The Jet Injectors Technology Market, 2014-2024
4.1 The Jet Injectors Market, 2012-2013
4.2 The Jet Injectors Market Forecast, 2014-2024
4.3 Leading Devices in the Jet Injectors Market, 2014
4.3.1 Biojector 2000 (Bioject Medical Technologies)
4.3.2 SUMAVEL DosePro (Zogenix)
4.3.3 E-Jet 100 (Eurojet Medical)
4.3.4 STRATIS (Pharmajet)
4.3.5 ZetaJet (Bioject Medical Technologies)
4.3.6 LectraJet (D’Antonio Consultants International)
4.3.7 Med-Jet (Medical International Technologies)
4.3.8 Vision (Antares Pharma)
4.3.9 Glide System (Glide Pharmaceutical Technologies)
4.3.10 AdvantaJet (Activa Brand Products)
4.3.11 J-Tip (National Medical Products)
4.3.12 SQ-Pen (Diabetes Management International)
4.3.13 Vitajet3 (Bioject Medical Technologies)
4.3.14 Penjet (Penjet Corporation)
4.3.15 INJEX30 (Injex)
4.4 Jet Injectors Development Pipeline, 2014
4.4.1 Zeneo (Crossject Medical Technologies)
4.4.2 Jupiter Jet (Bioject Medical Technologies)
4.4.3 Iject (Bioject Medical Technologies)
4.4.3.1 Iject R (Bioject Medical Technologies)
4.4.4 Relday (Zogenix)
4.5 Concluding Remarks
5. Competing Needle-Free Technology Market, 2014-2024
5.1 Competing Needle-Free Technologies: Overview
5.2 Competing Needle-Free Technology Market, 2012-2013
5.3 Competing Needle Free Technologies Market Forecast by Segments, 2014-2024
5.4 Novel Needle Technology Market, 2013
5.4.1 Novel Needle Technology Market Forecast, 2014-2024
5.4.2 Leading Products in the Microneedle Technology Market, 2014
5.4.3 Microneedle Patches for Vaccine Delivery, 2014
5.4.3.1 Microneedle Patch for the Polio Vaccine (Georgia Tech’s School of
Chemical and Biomolecular Engineering)
5.4.3.2 AdminPen (nanoBioSciences)
5.4.3.3 PKA SoftTouch (PKA SoftTouch Corp)
5.4.3.4 DrugMAT (TheraJect)
5.4.3.5 MicroCor (Corium International)
5.4.3.6 Nanopatch (Vaxxas)
5.4.3.7 ZP Patch Technology (Zosana)
5.5 Inhaler Technology Market, 2013
5.5.1 Inhaler Technology Market Forecast, 2014-2024
5.5.2 Inhalers in the Asthma Market, 2014
5.5.3 Inhalers in the Insulin Market, 2014
5.5.4 Inhalers in the Vaccine Market, 2014
5.6 The Patch Technology Market, 2013
5.6.1 The Patch Technology Market Forecast, 2014-2024
5.6.2 Drug Patches in the Market, 2014
5.7 Other Competing Needle-free delivery Technology in development
5.7.1 Magnetic Injection
5.7.2 Laser Injection
5.7.3 Vaccine Delivery Using Micro-Shock Waves (Indian Institute of Science, Bangalore)
5.7.4 Nanotechnology Syringes (Gwangju Institute of Science and Technology, South
Korea)
5.7.5 Nanotechnology Implant (University of California, San Francisco)
6. Leading National Needle-Free Delivery Markets, 2014-2024
6.1 Leading National Breakdown of the Needle-Free Delivery Market, 2012-2013
6.2 The Leading National Needle-Free Delivery Market Forecast, 2014-2024
6.3 The US Needle-Free Delivery Market Forecast, 2014-2024
6.4 The European Needle-Free Delivery Market, 2013
6.4.1 The European Needle-Free Delivery Market Forecast, 2014-2024
6.4.1.1 The German Needle-Free Delivery Market Forecast, 2014-2024
6.4.1.2 The French Needle-Free Delivery Market Forecast, 2014-2024
6.4.1.3 The Italian Needle-Free Delivery Market Forecast, 2014-2024
6.4.1.4 The Spanish Needle-Free Delivery Market Forecast, 2014-2024
6.4.1.5 The UK Needle-Free Delivery Market Forecast, 2014-2024
6.5 The Japanese Needle-Free Delivery Market Forecast, 2014-2024
6.6 The Chinese Needle-Free Delivery Market Forecast, 2014-2024
6.7 The Indian Needle-Free Delivery Market Forecast, 2014-2024
7. Leading Companies in the Needle-Free Delivery Market 2014
7.1 Antares Pharma
7.1.1 Sales and Performance Analysis
7.1.2 Product Sales, 2012
7.1.3 Revenue by Region, 2012
7.1.4 Revenue by Major Customers, 2011-2012
7.1.5 Sales and Performance Analysis, 3Q 2013
7.1.6 Technology of Antares Pharma
7.1.6.1 Pressure Assisted Injection Devices
7.1.6.2 Transdermal Gel System
7.1.7 Marketed Products, 2014
7.1.8 Pipeline Products, 2014
7.2 Zogenix
7.2.1 Sales and Performance Analysis
7.2.2 Sales by Segment, 2013
7.2.3 Needle-Free Products
7.2.3.1 Marketed Products, 2014
7.2.3.1.1 Sumavel® DosePro®: Rapid Acting Migraine Relief
7.2.3.1.2 Zohydro™ ER (hydrocodone bitartrate) Extended-Release Capsules
7.2.3.1.3 Zohydro™ ER Approval: Cause for Controversy?
7.2.3.1.4 Pipeline Products, 2014
7.2.4 Collaborations
7.2.4.1 Co-promotion of Migranal Nasal Spray with Valeant
7.2.5 Manufacturing
7.3 Bioject Medical Technologies
7.3.1 Sales and Performance Analysis
7.3.2 Sales Performance Analysis by Products
7.3.3 Sales and Performance Analysis, 3Q 2012-2013
7.3.4 Bioject’s Sales Revenue Setbacks
7.3.5 Collaborations
7.3.5.1 Navy Malaria Study: Utilises Bioject’s B2000 Technology
7.3.5.2 Cyto Pulse Sciences: Clinical Trials for an HIV/DNA vaccine
7.3.5.3 CDA intradermal influenza study
7.3.5.4 MPI Research: Seeking Drug/Device Combinations
7.3.5.5 World Health Organisation (WHO): The Push to Eradicate Infectious Disease in Developing Countries
7.3.6 Needle-Free Products
7.3.6.1 Biojector® 2000: Adaptable Power Source Allows Use in Home and Mass Vaccination Setting
7.3.6.2 Vitajet™: Low-cost Insulin Delivery System
7.3.6.3 ZetaJet™: Auto-disable Feature Improves User Safety
7.3.7 Needle-Free Injection Device Pipeline
7.3.7.1 Intradermal Pen Injector: Targeted Drug Delivery
7.3.7.2 Iject®: Providing Tailored Depth of Penetration
7.3.7.3 Jupiter Jet: Multi Dosing With Single Loaded Syringe
7.4 3M
7.4.1 Sales and Performance Analysis
7.4.2 3M Drug Delivery Systems
7.4.2.1 Inhalation
7.4.2.2 Transdermal patch
7.4.2.3 Microneedles
7.5 Medical International Technology (MIT)
7.5.1 Sales and Performance Analysis
7.5.2 Increased Product Awareness Through Globalisation
7.5.2.1 Further Expansion in China
7.5.3 Products
7.5.3.1 Med Jet
7.6 D’Antonio Consultants International (DCI)
7.6.1 Needle-Free Products
7.6.1.1 LectraJet®: Lightweight Device Reduces User Fatigue
7.6.2 Needle-Free Injection Device Pipeline
7.6.2.1 Low Workload Jet Injector: Single-shot Manual System
7.6.2.2 Multi Channel Jet Injector: For Simultaneous Vaccine Delivery
7.7 PharmaJet
7.7.1 Needle-Free Products
7.7.1.1 STRATIS®: Drug Delivery in Less Than a Second
7.7.1.2 Applications
7.7.2 Collaborations: Pursuing a Drug/Device Combination for Vaccine Administration
7.8 Akra Dermojet
7.8.1 Needle-Free Products
7.8.1.1 DERMOJET® “HR”: User-Friendly Design Allows Use in High Intensive Applications
7.8.1.2 DERMOJET Polymedical®: Interchangeable Injection Tips Reduces Risk of Contamination
7.8.1.3 Automatic DERMOJET®
7.9 Injex Pharma
7.9.1 Injex 30
7.9.1.1 Injex 30’s Applications
7.9.2 Injex’s Worldwide Distribution
7.9.2.1 Exclusive Distributor Agreement with Russia’s Medici Ltd.
7.9.2.2 Chinese SFDA approval
7.9.2.3 NHS’s Withdrawal of Injex30
7.10 Glide Pharma
7.10.1 Applications
7.10.1.1 Glide SDI system’s Advantages
7.10.2 Injecting Solid Formulations
7.10.3 Pharmaceutical Companies
7.10.4 Collaboration with Pfenex Inc. to Aid Delivery of Solid Dose Vaccine
8. Qualitative Analysis of the Needle-Free Delivery Market, 2014-2024
8.1 SWOT Analysis of the Needle-Free Delivery Market, 2014-2024
8.2 Strengths
8.2.1 Strong Growth in the Biologic Drug Market
8.2.2 Increasing Development in Transdermal Delivery
8.2.3 No Specialist Training Required for Drug/Vaccine Delivery
8.2.4 Eliminating the Cold Chain Problem
8.2.5 Reduction in Needle Stick Injuries
8.3 Weaknesses
8.3.1 Healthcare Practitioners are not Familiar with Novel Delivery Systems
8.3.2 Current Inefficient Manufacturing Processes Lead to Costly Needle-Free
Technology
8.3.3 Current Technology is Very Expensive
8.4 Opportunities
8.4.1 Emerging Economies Offer Significant Growth Opportunities
8.4.2 Mass Immunisation Programs Around the World
8.4.3 Increasing Global Diabetes Population
8.4.4 Shift Towards Home Administration Setting
8.4.5 Extending Life Cycle of Drugs
8.5 Threats
8.5.1 Traditional Needles and Syringes are Very Cheap to Mass Produce
8.5.1.1 Needle and Syringes with Anti Needle-Stick Injury Technology
8.5.2 Greater Regulatory Scrutiny
8.5.3 Limited Clinical Data
8.5.4 Medical Device Excise Tax
9. Expert Opinion
9.1 Interview with Robert E. Sievers, CEO and President, Aktiv-Dry LLC, and Professor,
Department of Chemistry and Biochemistry Center for Pharmaceutical Biotechnology, University of Colorado, Boulder
9.1.1 Aktiv-Dry’s PuffHaler
9.1.2 The Benefits of Inhaler Technology
9.1.3 The Competitive Landscape for Measles Inhaler Vaccines
9.1.4 ACTIV DRY’S Collaborations
9.1.5 The Challenges to Introduction Novel Inhaler Technology
9.2 Interview with David Hoey, CEO, Vaxxas
9.2.1 Vaxxas’s Nanopatch™ technology
9.2.2 The Advantages of Using Nanopatch Technology in Developed and Developing
Markets
9.2.3 The Challenges of Manufacturing Patch Technology
9.2.4 The Future for the Nanopatch Technology
9.3 Professor Mark Kendall, Inventor of the Nanopatch and Co-founder of Vaxxas
9.3.1 Microneedles: Proof of Concept to Commerical Product
9.3.2 Needle Delivery Market is Still Strong
9.3.3 The Microneedle Market
9.4 Interview with John Turanin, Vice President and General Manager, Zogenix Technologies
9.4.1 The Use of Gas Power in Jet Injectors
9.4.2 The Incentives for Drug Companies in Adopting Needle-Free Delivery
9.4.3 Regulating the Needle-Free Delivery Technology Market
9.4.4 Regional Market Forecasts for Jet Injectors
9.4.5 Jet Injectors: Competitive Space and Restraints on the Market
9.4.6 Regional Market Forecasts for Jet Injectors
9.4.7 Jet Injectors: Competitive Space and Restraints on the Market
9.5 Interview with Mark Logomasini, President and CEO, Bioject Medical Technologies
9.5.1 The Spring-Powered, Gas-Powered and Battery Powered Jet Injector Markets
9.5.2 Other Competing Needle-Free Delivery Platforms
9.5.3 Regulations Determine Jet Injector Market
9.5.4 Small Needle Free Delivery Companies Requires Large External Capital
10. Conclusions
10.1 The Needle-Free Delivery Market, 2014-2024
10.2 Transdermal Delivery For Vaccine Delivery
10.3 Biologic Drugs are a Major Driver of the Needle Free Delivery Market
10.4 Strong Pipeline Will Drive the Competing Needle-Free Injection Technology Market
10.5 Concluding Remarks
【レポート販売概要】
■ タイトル:ニードルフリー(無針)ドラッグデリバリー市場(2014-2024)■ 英文:Needle-Free Delivery: Technology and Market Forecast 2014-2024
■ 発行日:2014年4月
■ 調査会社:visiongain
■ 商品コード:Visiongain-405312
■ 調査対象地域:グローバル
- 分散データグリッドの世界市場2015-2019About distributed data grid Distributed data grids are data storage software. They represent a sub-segment of in-memory computing. Data grids store data in the RAMs of a set of multiple servers distributed across various locations, which can be managed centrally. Distributed data grids are versatile as they can store both structured as well as unstructured data. Distributed data grids have several …
- スマートグリッド及びスマートフォンによるエネルギー管理(Smart Grid and Smart Phones Putting Energy Management in the Hands of Consumers and Enterprise)As Smart Grid applications are deployed we will see decrease in the energy needs with 12% by 2030. However, this is not enough as there is a need for increased power supply. The primary reasons to increase worldwide energy efficiency can be grouped into four main factors: ■ Worldwide energy consumption is growing due to population growth and increased energy use per capita in both developed and de …
- インドのスキンケア市場動向(~2020)The skin care industry is a part of the FMCG sector, and is considered as one of the rapidly growing dynamic markets in India. Now-a-days, environmental aggression made the people very conscious about their skin care, as the skin is the largest organ in the human body and the most exposed to external conditions. The common skin problems faced by Indian people are skin darkening, patchy skin, acne …
- 急性気管支炎(Acute Bronchitis):世界の治験レビュー2014年下半期版Acute Bronchitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Acute Bronchitis Global Clinical Trials Review, H2, 2014" provides data on the Acute Bronchitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Bronchitis. It includes an overview of the trial numbers and their recruitment statu …
- 業務用サービスロボットの世界市場の世界市場Professional service robots have the tendency to work closely with humans and can be used in a wide application ranging from surveillance to underwater inspection. They provide convenience and safety, among other benefits, thus creating demand worldwide. Technavio expects the global professional service robotics market to multiply at a remarkable rate of nearly 16% during the forecast period. Toda …
- フラボノイドの世界市場分析:製品別(アントシアニン、フラボン、アンホキサンチン)、用途別(機能性飲料、機能性食品、栄養補助食品)、地域別(北アメリカ、ヨーロッパ、アジア太平洋、CSA、MEA)、セグメント予測、2014-2025Theglobal flavonoids market is expected to reach USD 1.06 billion by 2025, according to a new report by Grand View Research, Inc. Changing consumer lifestyles and rising demand for beauty & health supplements are expected to propel flavonoids consumption over the forecast period. Developed countries such as Denmark, France, Australia, Belgium, Norway, and the U.S. are characterized by high cancer …
- 非致死性兵器の世界市場2017-2021About Non-Lethal WeaponNon-lethal weapons, also known as less-lethal weapons, feature less intensity so that these do not kill a living target. These weapons are used in situations to limit the escalation of violence, as well as in scenarios where the use of lethal force is undesirable, or where policy restricts the employment of conventional force. These are used by military police and armed pers …
- 世界のコネクテッドカー市場:サービス別(OTAアップデート、ナビゲーション、サイバーセキュリティ、マルチメディアストリーミング、ソーシャルメディア、eコール、オートパイロット、ホームインテグレーション、その他)、フォーム別、エンド市場別(OE、アフターマーケット)、ネットワーク別、トランスポンダー別、ハードウェア別、地域別“Increase in demand for smartphone services and connectivity solutions in vehicles is the significant factor for the growth of the connected car market globally” The global connected car market is projected to reach USD 212.7 billion by 2027, from an estimated USD 42.6 billion in 2019, at a CAGR of 22.3%. All car makers such as Ford, BMW, Audi, Volvo, Hyundai, and Toyota offer some connectivity in …
- 小型武器の世界市場About Small Arms There is no standard definition for small arms. However, in general the terms 'small arms' and 'light weapons' are used for weapons of this category. These are in general small and light weight weapon that can be operated by one person. They usually include revolvers, pistols, rifles, submachine guns, light machine guns, heavy machine guns, grenade launchers, portable anti-aircraf …
- コールドチェーンの世界市場:冷蔵保存、冷蔵輸送The global cold chain market is projected to grow at a CAGR of 7.0% from 2015, to reach a value of USD 234.49 Billion by 2020. Cold chain includes refrigerated technology with temperature and humidity control throughout for perishable commodities such as milk, bakery & confectionery, dairy products, beverages, fresh fruits & vegetables, ice cream, frozen dairy products, and processed meat, fish & …
- 世界の真空熱処理市場:Global Vacuum Heat Treatment Market 2014-2018TechNavio's analysts forecast the Global Vacuum Heat Treatment Market to grow at a CAGR of 6.56 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need to develop high quality products. The Global Vacuum Heat Treatment Market has also been witnessing the integration of vacuum heat treatment process in production lines. However, the high initial inve …
- 中国のCOPD治療薬市場2016-2020About the Chronic Obstructive Pulmonary Disease (COPD) Drugs Market in China Chronic obstructive pulmonary disease (COPD) is a broad term that covers progressive lung diseases, including emphysema, chronic bronchitis, refractory (non-reversible) asthma, and some forms of bronchiectasis. It restricts airflow in the lungs and is characterized by diffculty breathing. The exact etiology of COPD is not …
- 世界の細胞表面マーカー市場The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next ten years, the main trend in cell surface marker analysis will …
- 慢性リンパ球性白血病(CLL):世界の臨床試験レビュー(2014年上半期)Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014" provides data on the Chronic Lymphocytic Leukemia (CLL) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Lymphocytic Leukemia (CLL). …
- アプリストアの将来(The Future of App Stores)There are now millions of mobile applications running on the popular mobile operating systems. Mobile applications are distributed via app stores which provide directory and search services that assist users in identify and acquiring the apps they most desire. This report provides a summary of the status of app stores in the market today. It presents a number of features common to all app stores. …